"Ropren® may be considered the flagship product of Solagran. However, it is quite
possible that in years to come, sales other forms of Bioeffective® R (including the
liposomal, injectable and nano-particle formats that have already been
developed) and even Bioeffective® A, may surpass those of Ropren®."
RM Research report
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.030(17.7%) |
Mkt cap ! $11.59M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 20.0¢ | 17.5¢ | $59.18K | 316.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14205 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 62269 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| SLA (ASX) Chart |